Brinkley Ruth Williams serves as Executive at Travere Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Brinkley Ruth Williams has executed 7 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Oct 31, 2025 involved receiving (via award) 97 shares valued at $0.
Brinkley Ruth Williams currently holds 5,316 shares of Travere Therapeutics, Inc. (TVTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Brinkley Ruth Williams has been a net neutral trader of TVTX stock. They have purchased $0 and sold $0 worth of shares.
Brinkley Ruth Williams's most recent insider trade was on Oct 31, 2025, when they sold 97 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 27, 2025 | NTRA | $0 | Award | 2,143 | $N/A | Discretionary |
| Jun 28, 2024 | NTRA | $0 | Award | 2,964 | $N/A | Discretionary |
| May 8, 2024 | TVTX | $0 | Award | 6,500 | $N/A | Discretionary |
| May 17, 2023 | TVTX | $0 | Award | 4,500 | $N/A | Discretionary |
| May 11, 2022 | TVTX | $0 | Award | 3,000 | $N/A | Discretionary |